insulin lispro protamine and insulin lispro injectable suspension mix75/25 kwikpen

Generic: insulin lispro

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name insulin lispro protamine and insulin lispro injectable suspension mix75/25 kwikpen
Generic Name insulin lispro
Labeler eli lilly and company
Dosage Form INJECTION, SUSPENSION
Routes
SUBCUTANEOUS
Active Ingredients

insulin lispro 100 [iU]/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-8233
Product ID 0002-8233_03dce3f6-da85-4635-9c62-478226005b60
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA021017
Listing Expiration 2026-12-31
Marketing Start 2020-02-12

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [chemical/ingredient]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00028233
Hyphenated Format 0002-8233

Supplemental Identifiers

RxCUI
847252
UNII
GFX7QIS1II
NUI
N0000004931 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name insulin lispro protamine and insulin lispro injectable suspension mix75/25 kwikpen (source: ndc)
Generic Name insulin lispro (source: ndc)
Application Number BLA021017 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE in 1 CARTON (0002-8233-05) / 3 mL in 1 SYRINGE (0002-8233-01)
source: ndc

Packages (1)

0002-8233-05 5 SYRINGE in 1 CARTON (0002-8233-05) / 3 mL in 1 SYRINGE (0002-8233-01)

Ingredients (1)

insulin lispro (100 [iU]/mL)

Linked Drug Pages (1)

Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "03dce3f6-da85-4635-9c62-478226005b60", "openfda": {"nui": ["N0000004931", "N0000175453"], "unii": ["GFX7QIS1II"], "rxcui": ["847252"], "spl_set_id": ["e49f701d-c19f-4cb2-b63f-01a917b33abc"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE in 1 CARTON (0002-8233-05)  / 3 mL in 1 SYRINGE (0002-8233-01)", "package_ndc": "0002-8233-05", "marketing_start_date": "20200212"}], "brand_name": "Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen", "product_id": "0002-8233_03dce3f6-da85-4635-9c62-478226005b60", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [Chemical/Ingredient]"], "product_ndc": "0002-8233", "generic_name": "Insulin lispro", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Insulin Lispro Protamine and Insulin Lispro Injectable Suspension", "brand_name_suffix": "Mix75/25 KwikPen", "active_ingredients": [{"name": "INSULIN LISPRO", "strength": "100 [iU]/mL"}], "application_number": "BLA021017", "marketing_category": "BLA", "marketing_start_date": "20200212", "listing_expiration_date": "20261231"}